Among these are genetic variants (see below) and exposure to cytokines and viral infections in type 1 diabetes and to free fatty acids, glucose, islet amyloid polypeptide (IAPP), and increased β cell workload due to insulin resistance in type 2 diabetes. This evidence concerns the gene IAPP and type 1 diabetes mellitus.